A long-time survivor of alpha-fetoprotein-producing gastric cancer successfully treated by fluoropyrimidine-based chemotherapy

A case study

Masatsugu Hiraki, Seiji Sato, Keita Kai, Ohtsuka Takao, Naohiko Kohya, Yoshihiko Kitajima, Yuji Nakafusa, Osamu Tokunaga, Kohji Miyazaki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 67-year-old male with advanced gastric cancer and lymph node metastasis as well as a tumor embolus in the portal vein was treated by S-1/cisplatin therapy. The serum alpha-fetoprotein levels were elevated to 836 ng/ml at the first visit. After one course of chemotherapy, the patient showed stable disease; the serum level of alpha-fetoprotein also decreased to 626 ng/ml after a transient increase, and therefore reduction surgery was performed. A total gastrectomy with a distal pancreatectomy, splenectomy, and regional lymph node dissection was performed. The resected specimen was diagnosed to be alpha-fetoprotein-producing gastric cancer. There were no metastatic foci in the resected lymph nodes, presumably due to the preoperative chemotherapy. S-1/cisplatin therapy was continued after the operation to treat the remaining tumor embolus in the portal vein. After one course of this therapy, the tumor embolus disappeared. However, a lymph node measuring 1.5 cm in diameter appeared in the hepatoduodenal ligament. Therefore, the chemotherapy was changed to paclitaxel monotherapy. After 2 courses of paclitaxel monotherapy, the lymph node swelled, and thus 5′-deoxy-5-fluorouridine was added to the paclitaxel regimen. After 5 courses of this regimen, the lymph node swelling disappeared without any other new lesions and a total of 21 courses were performed. The patient remained stable for over 8 years without recurrence. The expression of chemoresistance-related proteins was retrospectively analyzed by immunohistochemistry to evaluate the chemoresistance. The ortate phosphoribosyltransferase expression was strongly positive, and the good outcome in this case may have been associated with this result.

Original languageEnglish
Pages (from-to)331-337
Number of pages7
JournalClinical Journal of Gastroenterology
Volume2
Issue number5
DOIs
Publication statusPublished - Oct 1 2009

Fingerprint

alpha-Fetoproteins
Stomach Neoplasms
Survivors
Lymph Nodes
Drug Therapy
Paclitaxel
Embolism
Portal Vein
Cisplatin
Neoplasms
Pancreatectomy
Splenectomy
Gastrectomy
Lymph Node Excision
Serum
Ligaments
Therapeutics
Immunohistochemistry
Neoplasm Metastasis
Recurrence

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

A long-time survivor of alpha-fetoprotein-producing gastric cancer successfully treated by fluoropyrimidine-based chemotherapy : A case study. / Hiraki, Masatsugu; Sato, Seiji; Kai, Keita; Takao, Ohtsuka; Kohya, Naohiko; Kitajima, Yoshihiko; Nakafusa, Yuji; Tokunaga, Osamu; Miyazaki, Kohji.

In: Clinical Journal of Gastroenterology, Vol. 2, No. 5, 01.10.2009, p. 331-337.

Research output: Contribution to journalArticle

Hiraki, Masatsugu ; Sato, Seiji ; Kai, Keita ; Takao, Ohtsuka ; Kohya, Naohiko ; Kitajima, Yoshihiko ; Nakafusa, Yuji ; Tokunaga, Osamu ; Miyazaki, Kohji. / A long-time survivor of alpha-fetoprotein-producing gastric cancer successfully treated by fluoropyrimidine-based chemotherapy : A case study. In: Clinical Journal of Gastroenterology. 2009 ; Vol. 2, No. 5. pp. 331-337.
@article{3aa9aa66b6d146f981a290119000a987,
title = "A long-time survivor of alpha-fetoprotein-producing gastric cancer successfully treated by fluoropyrimidine-based chemotherapy: A case study",
abstract = "A 67-year-old male with advanced gastric cancer and lymph node metastasis as well as a tumor embolus in the portal vein was treated by S-1/cisplatin therapy. The serum alpha-fetoprotein levels were elevated to 836 ng/ml at the first visit. After one course of chemotherapy, the patient showed stable disease; the serum level of alpha-fetoprotein also decreased to 626 ng/ml after a transient increase, and therefore reduction surgery was performed. A total gastrectomy with a distal pancreatectomy, splenectomy, and regional lymph node dissection was performed. The resected specimen was diagnosed to be alpha-fetoprotein-producing gastric cancer. There were no metastatic foci in the resected lymph nodes, presumably due to the preoperative chemotherapy. S-1/cisplatin therapy was continued after the operation to treat the remaining tumor embolus in the portal vein. After one course of this therapy, the tumor embolus disappeared. However, a lymph node measuring 1.5 cm in diameter appeared in the hepatoduodenal ligament. Therefore, the chemotherapy was changed to paclitaxel monotherapy. After 2 courses of paclitaxel monotherapy, the lymph node swelled, and thus 5′-deoxy-5-fluorouridine was added to the paclitaxel regimen. After 5 courses of this regimen, the lymph node swelling disappeared without any other new lesions and a total of 21 courses were performed. The patient remained stable for over 8 years without recurrence. The expression of chemoresistance-related proteins was retrospectively analyzed by immunohistochemistry to evaluate the chemoresistance. The ortate phosphoribosyltransferase expression was strongly positive, and the good outcome in this case may have been associated with this result.",
author = "Masatsugu Hiraki and Seiji Sato and Keita Kai and Ohtsuka Takao and Naohiko Kohya and Yoshihiko Kitajima and Yuji Nakafusa and Osamu Tokunaga and Kohji Miyazaki",
year = "2009",
month = "10",
day = "1",
doi = "10.1007/s12328-009-0105-9",
language = "English",
volume = "2",
pages = "331--337",
journal = "Clinical Journal of Gastroenterology",
issn = "1865-7257",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - A long-time survivor of alpha-fetoprotein-producing gastric cancer successfully treated by fluoropyrimidine-based chemotherapy

T2 - A case study

AU - Hiraki, Masatsugu

AU - Sato, Seiji

AU - Kai, Keita

AU - Takao, Ohtsuka

AU - Kohya, Naohiko

AU - Kitajima, Yoshihiko

AU - Nakafusa, Yuji

AU - Tokunaga, Osamu

AU - Miyazaki, Kohji

PY - 2009/10/1

Y1 - 2009/10/1

N2 - A 67-year-old male with advanced gastric cancer and lymph node metastasis as well as a tumor embolus in the portal vein was treated by S-1/cisplatin therapy. The serum alpha-fetoprotein levels were elevated to 836 ng/ml at the first visit. After one course of chemotherapy, the patient showed stable disease; the serum level of alpha-fetoprotein also decreased to 626 ng/ml after a transient increase, and therefore reduction surgery was performed. A total gastrectomy with a distal pancreatectomy, splenectomy, and regional lymph node dissection was performed. The resected specimen was diagnosed to be alpha-fetoprotein-producing gastric cancer. There were no metastatic foci in the resected lymph nodes, presumably due to the preoperative chemotherapy. S-1/cisplatin therapy was continued after the operation to treat the remaining tumor embolus in the portal vein. After one course of this therapy, the tumor embolus disappeared. However, a lymph node measuring 1.5 cm in diameter appeared in the hepatoduodenal ligament. Therefore, the chemotherapy was changed to paclitaxel monotherapy. After 2 courses of paclitaxel monotherapy, the lymph node swelled, and thus 5′-deoxy-5-fluorouridine was added to the paclitaxel regimen. After 5 courses of this regimen, the lymph node swelling disappeared without any other new lesions and a total of 21 courses were performed. The patient remained stable for over 8 years without recurrence. The expression of chemoresistance-related proteins was retrospectively analyzed by immunohistochemistry to evaluate the chemoresistance. The ortate phosphoribosyltransferase expression was strongly positive, and the good outcome in this case may have been associated with this result.

AB - A 67-year-old male with advanced gastric cancer and lymph node metastasis as well as a tumor embolus in the portal vein was treated by S-1/cisplatin therapy. The serum alpha-fetoprotein levels were elevated to 836 ng/ml at the first visit. After one course of chemotherapy, the patient showed stable disease; the serum level of alpha-fetoprotein also decreased to 626 ng/ml after a transient increase, and therefore reduction surgery was performed. A total gastrectomy with a distal pancreatectomy, splenectomy, and regional lymph node dissection was performed. The resected specimen was diagnosed to be alpha-fetoprotein-producing gastric cancer. There were no metastatic foci in the resected lymph nodes, presumably due to the preoperative chemotherapy. S-1/cisplatin therapy was continued after the operation to treat the remaining tumor embolus in the portal vein. After one course of this therapy, the tumor embolus disappeared. However, a lymph node measuring 1.5 cm in diameter appeared in the hepatoduodenal ligament. Therefore, the chemotherapy was changed to paclitaxel monotherapy. After 2 courses of paclitaxel monotherapy, the lymph node swelled, and thus 5′-deoxy-5-fluorouridine was added to the paclitaxel regimen. After 5 courses of this regimen, the lymph node swelling disappeared without any other new lesions and a total of 21 courses were performed. The patient remained stable for over 8 years without recurrence. The expression of chemoresistance-related proteins was retrospectively analyzed by immunohistochemistry to evaluate the chemoresistance. The ortate phosphoribosyltransferase expression was strongly positive, and the good outcome in this case may have been associated with this result.

UR - http://www.scopus.com/inward/record.url?scp=77953413423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953413423&partnerID=8YFLogxK

U2 - 10.1007/s12328-009-0105-9

DO - 10.1007/s12328-009-0105-9

M3 - Article

VL - 2

SP - 331

EP - 337

JO - Clinical Journal of Gastroenterology

JF - Clinical Journal of Gastroenterology

SN - 1865-7257

IS - 5

ER -